ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 C18.9

Billable / Specific HCC v28: 11 CC

Malignant neoplasm of colon, unspecified

C18
Block
1
Synonyms
1,347
LCDs
67
Payer Policies
58
Linked CPTs

About ICD-10-CM C18.9

ICD-10-CM code C18.9 represents Malignant neoplasm of colon, unspecified. This is a billable/specific code in the Neoplasms chapter (block C18). The 2026 edition of ICD-10-CM C18.9 became effective on October 1, 2025.

Coding Tips for C18.9

Specialist guidance from the PayerReady Medical Coding Team. Specificity warnings, HCC capture rules, sequencing notes.

HCC capture: document with MEAT each year

C18.9 is a CMS-HCC v28 risk-adjustment code (category 11). To count for the patient Risk Adjustment Factor (RAF), document the diagnosis with MEAT language each calendar year: Monitored, Evaluated, Assessed, Treated. A diagnosis on the problem list alone does not satisfy CMS RADV audit standards. Include the diagnosis in the assessment with current status and current treatment plan.

Inpatient DRG impact: CC

C18.9 is designated CC for MS-DRG grouping. On inpatient claims, this code can shift the DRG to the with-CC variant when documented as a present-on-admission secondary diagnosis. Hospital CDI programs flag CC opportunities during chart review. Failure to capture this code may leave 30 to 80 percent of the inpatient stay revenue unrealized.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under C18.9. Per CMS ICD-10-CM Tabular 2026.

  • Malignant neoplasm of large intestine NOS

Medicare Advantage HCC Impact

CMS-HCC v28 (current)
Category 11
ESRD-HCC
Category 11
RxHCC (Part D)
Category 11

Capture this diagnosis annually for accurate risk adjustment. Missed HCC captures are the #1 revenue leak in Medicare Advantage risk programs.

Inpatient DRG Impact, CC

codes Malignant neoplasm of colon, unspecified. As a Complication/Comorbidity (CC), this contributes to DRG severity adjustment when documented alongside the principal diagnosis.

Medicare LCD Coverage for C18.9

Local Coverage Determinations (LCDs) from CMS MACs that list C18.9 as a covered diagnosis.

1,347 LCDs

Showing top 10 of 1,347 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 74170 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 74177 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 74160 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 74178 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 74150 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 72194 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 74176 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 72192 →
CMS LCD: Billing and Coding: CT of the Abdomen and Pelvis
Article ID: 56421, Effective: 2025-11-01 00:00:00, 5389 covered, 0 non-covered
CPT 72193 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
Article ID: 60240, Effective: , 680 covered, 0 non-covered
CPT 81479 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing C18.9.

67 policies

5 Medicare

Billing and Coding: Bevacizumab and biosimilars
Policy ID: ART-52370
Oral Anticancer Drugs - Policy Article
Policy ID: ART-52479
Billing and Coding: Biomarkers for Oncology
Policy ID: ART-52986
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID� Update
Policy ID: ART-53101
MolDX: Oncotype DX� Colon Cancer Assay Update
Policy ID: ART-53106

CPT Codes Commonly Billed with C18.9

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

58 linkages
  • 74177 CT abdomen/pelvis with contrast — abdominal pain, colon cancer staging, liver mets, cholelithiasis, pancreatitis, chronic pancreatitis, pancreatic cancer, hepatomegaly, splenomegaly, abnormal imaging Radiology
  • 74176 CT abdomen/pelvis without contrast — same indications as with contrast when contrast contraindicated Radiology
  • 81210 CMS LCD: Billing and Coding: MolDX: FDA-Approved BRAF Tests CMS LCD
  • 81540 CMS LCD: Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID� Update CMS LCD
  • 45341 CMS LCD: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic CMS LCD
  • 45331 CMS LCD: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic CMS LCD
  • 45337 CMS LCD: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic CMS LCD
  • 45332 CMS LCD: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic CMS LCD
  • 45334 CMS LCD: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic CMS LCD
  • 45335 CMS LCD: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic CMS LCD

Convert C18.9 to ICD-9-CM

Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.

ICD-10ICD-9Mapping Flags
C18.9 1539 00000

Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).

ICD-10 C18.9, Billing FAQ

Is ICD-10 code C18.9 billable? +

Yes, C18.9 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to C18.9? +

ICD-10 C18.9 includes: Malignant neoplasm of large intestine NOS.

Does C18.9 affect Medicare Advantage HCC risk adjustment? +

Yes. C18.9 maps to CMS-HCC v28 category 11. Capture this diagnosis annually for accurate Medicare Advantage risk score.

Is C18.9 a CC or MCC for inpatient DRG? +

Yes, this code is designated as CC. Documenting as a secondary diagnosis on inpatient claims can shift the DRG to a higher-weighted category.

What CPT codes are commonly billed with C18.9? +

Procedures frequently paired with C18.9 include: 74177, 74176, 81210, 81540, 45341.

What ICD-9 codes does C18.9 map to? +

Per CMS GEMs, C18.9 maps to ICD-9 codes: 1539. Useful for legacy data review and historical claim analysis.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on June 2, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included